🕵️ COYA Therapeutics, Inc. ($COYA)
SEC insider & ownership activity, last 12 months · CIK 1835022 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| DME Advisors GP, L.L.C. | 9.9% | 13G | Feb 14, 2025 | filing ↗ | |
| Einhorn David | 9.9% | 13G | Feb 14, 2025 | filing ↗ | |
| DR. Reddy'S Laboratories, Inc. | 9.7% | 13G | Mar 12, 2026 | filing ↗ | |
| Dr. Reddy'S Laboratories Sa | 9.7% | 13G | Mar 12, 2026 | filing ↗ | |
| Dr. Reddy'S Laboratories Limited | 9.7% | 13G | Mar 12, 2026 | filing ↗ | |
| DME Capital Management, LP | 7.6% | 13G | Feb 14, 2025 | filing ↗ | |
| Orin Hirschman | exited | 13G | Jul 27, 2026 | filing ↗ | |
| AIGH Capital Management LLC | exited | 13G | Jul 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 25, 2026 | filing ↗ |
| Material agreement (1.01) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Other events (8.01) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 29, 2026 | filing ↗ |
| Earnings (2.02) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 29, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 29, 2026 | filing ↗ |
| Other events (8.01) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Other events (8.01) | Jan 20, 2026 | filing ↗ |
| Other events (8.01) | Jan 8, 2026 | filing ↗ |
| Other events (8.01) | Dec 16, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 23, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 23, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 23, 2025 | filing ↗ |
| Other events (8.01) | Aug 29, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |